About Ingeneron
Ingeneron is a company based in Houston (United States) founded in 2005. Ingeneron has raised $51.4 million across 5 funding rounds from investors including Sanford Health. Ingeneron operates in a competitive market with competitors including Horizon Therapeutics, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$51.4 M (USD)
in 5 rounds
-
Latest Funding Round
$1.75 M (USD), Series D
Feb 16, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ingeneron
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Software Development Team
2 people
Finance and Accounting
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Ingeneron
Ingeneron has successfully raised a total of $51.4M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $1.75 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ingeneron
Ingeneron has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sanford Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Operator of integrated healthcare system providing medical services and health plans
|
Locked | Locked | Locked |
Investor details for Ingeneron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ingeneron
Investment portfolio details for Ingeneron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ingeneron
Detailed financials for Ingeneron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ingeneron Comparisons
Peer comparison for Ingeneron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ingeneron
Ingeneron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Avidity Biosciences, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drugs for treating rare and autoimmune diseases
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Ingeneron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ingeneron
Complete news archive for Ingeneron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ingeneron
Ingeneron was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Ingeneron is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Ingeneron is a funded company, having raised a total of $51.4M across 5 funding rounds to date.
Ingeneron was founded in 2005 and is based in Houston, United States. Cell-based technologies are provided for healthcare, veterinary medicine, and life science research. Adipose-derived regenerative cells, including stem cells, are isolated through proprietary separation methods. These cells are utilized in treatments for diseases, orthopedic injuries, and cosmetic procedures by medical professionals.
Ingeneron's top competitors include Sutro Biopharma, Horizon Therapeutics and Avidity Biosciences.
Ingeneron has 1 investor. Key investors include Sanford Health.